- 180 Life Sciences Corp's ATNF Clinical Advisory Board Chairman, Jagdeep Nanchahal, will present a keynote talk at the British Society for Surgery of the Hand (BSSH) meeting.
- The meeting is scheduled for September 9, 2021, at 9:00 AM British Standard Time (4:00 AM ET).
- Professor Nanchahal will present an overview of his scientific research in defining the molecular pathways of the fibrotic process in Dupuytren's disease, which causes the fingers to curl irreversibly into the palm, and potential therapeutic approaches.
- Professor Jagdeep Nanchahal commented, "By systematically analyzing tissues normally discarded at the time of surgery, we were able to identify a potential therapeutic target and progress through to testing in patients with early-stage Dupuytren's disease."
- Price Action: ATNF shares closed at $7.57 on Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
